More Information

At Gilead, we are working to combat life-threatening diseases by inventing medicines that represent improvements over existing options. An important aspect of these efforts is to ensure patients who need our medicines receive them worldwide, particularly in resource-limited countries.

The Gilead Access Program prioritizes the effective management of production, product registration, distribution, medical education and stakeholder engagement to ensure sustainable access to Gilead therapeutics in the developing world.

Gilead's International Access Operations team leads this Program for HIV/AIDS and Leishmaniasis treatment in developing countries.

Click here to download an overview of Gilead's Access Program.

Next >>